2 citations · 2 across the 1 of their papers we have counts for
1 paper
Abigail J. Burdon, Lisa V. Hampson, Christopher Jennison
Often in Phase 3 clinical trials measuring a long-term time-to-event endpoint, such as overall survival or progression-free survival, investigators also collect repeated measures o…